FierceBiotech 9 dic 2025 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
FierceBiotech 5 dic 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
FierceBiotech 3 dic 2025 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
FierceBiotech 25 nov 2025 <a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a> #mRNA flu #Pfizer mRNA